Evidence map›Paper›PMID 28784675›Full record

ArticleAntimicrobial agents and chemotherapy2017

Pharmacokinetics of Cefuroxime in Synovial Fluid.

R Schwameis, S Syré, D Marhofer, A Appelt, D Burau, K Sarahrudi, C Kloft, M Zeitlinger

Open access · bronzeAbstract readClinical Trial, Phase I
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Linezolid brain penetration in neurointensive care patients.The Journal of antimicrobial chemotherapy · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

R SchwameisDepartment of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
S SyréDepartment of Trauma Surgery, Medical University of Vienna, Vienna, Austria.
D MarhoferDepartment of Anaesthesia, Intensive Care Medicine, and Pain Therapy, Medical University of Vienna, Vienna, Austria.
A AppeltDepartment of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
D BurauDepartment of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
K SarahrudiDepartment of Trauma Surgery, Medical University of Vienna, Vienna, Austria.
C KloftDepartment of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
M ZeitlingerDepartment of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria markus.zeitlinger@meduniwien.ac.at.
Medical University of Vienna · ATFreie Universität Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cefuroxime is frequently used as preoperative antibiotic prophylaxis and may be used for the treatment of septic arthritis. A prerequisite for successful treatment of septic arthritis is the ability of an antibiotic agent to penetrate into the target site. Therefore, the concentration of cefuroxime in synovial fluid was evaluated. Ten patients who underwent elective knee arthroscopy were included in this study. Patients were treated with a single dose of 1,500 mg cefuroxime intravenously, and subsequently, the concentrations in plasma, the interstitial fluid of muscle tissue, and synovial fluid were measured by using microdialysis. Pharmacokinetic/pharmacodynamic calculations to predict bacterial killing were performed using the epidemiologically defined MIC

Indexed as

CefuroximeAdultAnti-Bacterial AgentsArthritis, InfectiousArthroscopyFemaleHumansMaleMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMiddle AgedStaphylococcus epidermidisSynovial FluidYoung AdultAnti-Bacterial AgentsCefuroximebacteriadrug tissue concentrationin vivo pharmacokineticsmicrodialysisseptic arthritis

Identifiers

PMID28784675
PMCPMC5610482
OpenAlexW2743330961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.